Prognostic Value of NT-proBNP in Patients Treated With Allogeneic Stem Cell Transplantation
Baseline NT-proBNP in patients treated with alloSCT is positively associated with an increased risk of all-cause mortality. NT-proBNP ≥125 ng/L was associated with a significant lower 5-year survival.
Authors
- J. Wouter Jukema (ORCID: https://orcid.org/0000-0002-3246-8359)
- Julius C. Heemelaar (ORCID: https://orcid.org/0000-0001-6892-5227)
- E Polomski (ORCID: https://orcid.org/0000-0001-9890-8620)
- Peter A. von dem Borne (ORCID: https://orcid.org/0000-0002-7470-7346)
- Hendrik Veelken (ORCID: https://orcid.org/0000-0002-9108-3125)
- M. Louisa Antoni (ORCID: https://orcid.org/0000-0003-1831-6698)
Institutions
- Leiden University Medical Center (NL)
- Netherlands Heart Institute (NL)
Publication Details
- Journal
- JACC Advances
- Published
- 2025-12-11
- DOI
- https://doi.org/10.1016/j.jacadv.2025.102415
- Primary Topic
- Hematopoietic Stem Cell Transplantation
- Type
- article
- Field-Weighted Citation Impact
- 0.00